NL
DE
The Radboudumc Research Institute is taking a new step in international collaboration. Prof. Bernd Weber, Dean of the Medical Faculty at the University of Bonn, visited Radboudumc with a delegation of senior scientists for a two-day working visit. The meeting followed the earlier visit of our rector, José Sanders, to Bonn this spring and is part of a deliberate effort to further strengthen and structure collaboration between both institutions.
The University of Bonn is one of Germany’s Excellence Universities, with an outstanding reputation in medical and life science research. Researchers from Bonn and Radboudumc already work closely together in areas such as immunology, neuroscience and genetics. A good example is Mihai Netea’s part-time appointment in Bonn, which already serves as a strong bridge between the two institutions.
During the visit, Radboudumc and Bonn agreed to sign a Memorandum of Understanding to make it easier to exchange biomaterials and data. Both sides also expressed the ambition to increase the number of joint grant applications, for example within Horizon Europe and ERC Synergy schemes, and to stimulate postdoc exchange, including through Marie Skłodowska-Curie Fellowships.
Several concrete ideas for new collaborations were identified in immunology, neuroscience and AI research. To support these and future initiatives, the two institutions plan to align their core research facilities – from protocols to sharing instruments, biomaterials and data – and to enable multi-center trials across Nijmegen and Bonn. Internally, both sides will better synchronize their grant support processes so they can more easily consider each other as partners for collaborative EU proposals.
It is still early days, and specific outcomes cannot yet be predicted. But the direction is clear: building a long-term, trust-based partnership to tackle major scientific and medical challenges together.
As Guillén Fernandez puts it: “With Bonn, we connect to one of Europe’s most dynamic academic research hubs – close in distance, strong in quality, and united by a shared ambition to make science matter for patients.”
-
Want to know more about these subjects? Click on the buttons below for more news.
